3 Cos. Launch IPOs Totaling $250M Amid Early Feb. Rush
A gene-editing company and a medical technology business on Monday launched initial public offerings projected to raise about $175 million combined — following a cancer-focused biotechnology firm's announcement Friday that it...To view the full article, register now.
Already a subscriber? Click here to view full article